Research Associate — Kidney & Cardiovascular Metabolic Disease

University of Pennsylvania; United States; On-site; USD 65,000 - 90,000; Full time

Job summary

University of Pennsylvania is seeking a Research Associate in the Renal-Electrolyte and Hypertension division. The role focuses on molecular and cellular mechanisms underlying kidney and cardiovascular-metabolic diseases, with emphasis on diabetic kidney disease and SGLT2 inhibitor responses.

The position offers collaboration with premier investigators and access to cutting-edge omics technologies. The successful candidate will design and lead biomedical experiments, utilize genetically modified

Qualifications

• MD or MD/PhD required.
• Experience in molecular biology and experimental design.
• Experience with single-cell or spatial transcriptomics is highly desirable.

Responsibilities

• Design and conduct biomedical research on kidney and cardiovascular-metabolic diseases.
• Use genetically modified mouse models to study disease mechanisms.
• Perform molecular biology techniques, gene expression analysis, and cell isolation/culture.
• Conduct computational analyses of omics and spatial transcriptomic data.
• Integrate multi-omics data to identify disease mechanisms and therapeutic responses.
• Collaborate with multidisciplinary teams and external facilities.

Skills

Molecular biology

Computational analysis

Experimental design

GM animal models

Single-cell RNA-seq

Spatial transcriptomics

Multi-omics data

Gene expression analysis

Primary cell culture

Functional validation

Education

MD or MD/PhD

Job description

University of Pennsylvania is seeking a Research Associate in the Renal-Electrolyte and Hypertension division. The role focuses on molecular and cellular mechanisms underlying kidney and cardiovascular-metabolic diseases, with emphasis on diabetic kidney disease and SGLT2 inhibitor responses.

The position offers collaboration with premier investigators and access to cutting-edge omics technologies. The successful candidate will design and lead biomedical experiments, utilize genetically modified